Multiplexed Prostate Cancer Companion Diagnostic Devices
Prostate cancer (PCa) remains one of the most prominent forms of cancer for men. Since the early 1990s, Prostate-Specific Antigen (PSA) has been a commonly recognized PCa-associated protein biomarker. However, PSA testing has been shown to lack in specificity and sensitivity when needed to diagnose,...
Main Authors: | Josephine Aidoo-Brown, Despina Moschou, Pedro Estrela |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/21/15/5023 |
Similar Items
-
Organizational challenges in the management of point-of-care diagnostics in healthcare facilities
by: Kachler Marco, et al.
Published: (2020-04-01) -
Personalized medicine: biomarkers and companion diagnostics
by: Renato Bernardini, et al.
Published: (2018-03-01) -
REASSURED Multiplex Diagnostics: A Critical Review and Forecast
by: Jonas A. Otoo, et al.
Published: (2022-02-01) -
Next-Generation Intelligent MXene-Based Electrochemical Aptasensors for Point-of-Care Cancer Diagnostics
by: Arpana Parihar, et al.
Published: (2022-04-01) -
Alternate Antimicrobial Therapies and Their Companion Tests
by: Sriram Kalpana, et al.
Published: (2023-07-01)